Comprehensive breast cancer screening: Programs now include individual risk assessment

Postgraduate Medicine

Volumn 113, Issue 2, 2003, Pages 34-46

  Cardenas, Kim ^a   Frisch, Kelly ^b  

^a REGIONS HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST EXAMINATION; CANCER PREVENTION; CANCER SCREENING; CANCER STAGING; CONFERENCE PAPER; FAMILY HISTORY; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MEDICAL CARE; PATIENT CARE; PRACTICE GUIDELINE; RISK ASSESSMENT;

EID: 0037331979     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2003.02.1370     Document Type: Conference Paper

References (22)

1. Breast cancer facts and figures, 2001. Atlanta: American Cancer Society, 2001
2. Garfinkel L, Boring CC, Heath CW Jr. Changing trends: an overview of breast cancer incidence and mortality. Cancer 1994;74(1 Suppl):222-7
3. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996;275(12):913-8
4. Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87(22):1681-5
5. Greene MH. Genetics of breast cancer. Mayo Clin Proc 1997;72(1):54-65
6. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer: a guide for clinicians. JAMA 1995;273(7):577-85
7. Pinsky LE, Culver JB, Hull J, et al. Why should primary care physicians know about breast cancer genetics? West J Med 2001;175(3):168-73
8. ACOG committee opinion. Breast-ovarian cancer screening. No. 239, Aug 2000. American College of Obstetricians and Gynecologists. Committee on genetics. Int J Gynaecol Obstet 2001;75(3):339-40
9. Keating NL, Cleary PD, Rossi AS, et al. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med 1999;130(7):545-53
10. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288(3):321-33
11. Baxter N. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 2001;164(13):1837-46
12. Screening for breast cancer: recommendations and rationale. Rockville, Md: Agency for Healthcare Research and Quality, 2002
13. Blamey RW, Wilson AR, Patnick J. ABC of breast diseases: screening for breast cancer. BMJ 2000;321(7262):689-93
14. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273(2):149-54
15. Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. Can Med Assoc J 2001;164(4):469-76
16. Hendrick RE, Smith RA, Rutledge JH III, et al. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1997;(22):87-92
17. Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338(16):1089-96
18. Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87(10):720-31
19. Gail MH, Brinton LA, Byar DP. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81(24):1879-86
20. Costantino JP, Gail MH, Pee D, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91(18):1541-8
21. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. N Engl J Med 2000;342(8):564-71
22. Fisher B, Costantino JP, Wickerham DL. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90(18):1371-88